Estrogenic activities of fatty acids and a sterol isolated from royal jelly

Evidence-based Complementary and Alternative Medicine

Volumn 5, Issue 3, 2008, Pages 295-302

  Suzuki, Kazu Michi ^a   Isohama, Yoichiro ^b   Maruyama, Hiroe ^a   Yamada, Yayoi ^a   Narita, Yukio ^a   Ohta, Shozo ^a   Araki, Yoko ^a   Miyata, Takeshi ^b,c   Mishima, Satoshi ^a  

^a Api Company Ltd   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

10 Hydroxy 2 decenoic acid; 10 Hydroxydecanoic acid; 2 Decenoic acid; 24 Methylenecholesterol; Apis mellifera

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; 10 HYDROXYDECANOIC ACID; 2 DECENOIC ACID; 24 METHYLENECHOLESTEROL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL; FATTY ACID DERIVATIVE; PHYTOESTROGEN; ROYAL JELLY; STEROL DERIVATIVE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ISOLATION; ENDOMETRIUM; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENETIC TRANSCRIPTION; HONEYBEE; HORMONE BINDING; HUMAN; HUMAN CELL; HYPERTROPHY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; UTERUS WEIGHT;

EID: 51849140979     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem036     Document Type: Article

References (33)

1. Rymer J, Wilson R, Ballard K. Making decisions about hormone replacement therapy. Br Med J 2003;326:322-6.
2. Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 2003;105:408-12.
3. Humphries KH, Gill S. Risks and benefits of hormone replacement therapy: the evidence speaks. Can Med Assoc J 2003;168:1001-10.
4. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr [B] 2002;777:233-48.
5. Beck V, Rohr U, Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 2005;94:499-518.
6. Mateescu C, Barbulescu D. Enhanced nutritive, functional and therapeutic action of combined bee products in complex food supplements. Roum Biotechnol Lett 1999;4:163-72.
7. Fujii A. Pharmacological effect of royal jelly. Honeybee Sci 1995;16:97-104 (in Japanese).
8. Kushima K, Hasegawa N. Menopausal disorder. J Ther 1972;54:578-84 (in Japanese).
9. Kushima K, Hasegawa N, Ogawa E. Effects of royal jelly on autonomic imbalance in menopausal women. World Obstet Gynecol 1973;25:439-43 (in Japanese).
10. Mishima S, Suzuki KM, Isohama Y, Kuratsu N, Araki Y, Inoue M, et al. Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol 2005;101:215-20.
11. Mishima S, Miyata T, Suzuki KM, Araki Y, Akao Y, Isohama Y. Estrogenic effects of royal jelly. J Tradit Med 2005;22(Suppl 1): 171-5.
12. Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 1978;253:2223-8.
13. Catherino WH, Jordan VC. The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells. Cancer Lett 1995;90:35-42.
14. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
15. Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Richardson BD, et al. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 2003;72:314-30.
16. 24(28) phytosterols. Org Magn Reson 1980;13:302-3.
17. Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ Health Perspect 2001;109:785-94.
18. Noda S, Sawaki M, Shiraishi K, Yamasaki K, Yamaguchi R. Age-related changes of genital systems in the female Crj:CD (SD) IGS rats during sexual maturation. J Vet Med Sci 2002;64:315-9.
19. Scarselli R, Donadio E, Giuffrida MG, Fortunato D, Conti A, Balestreri E, et al. Towards royal jelly proteome. Proteomics 2005;5:769-76.
20. Svoboda JA, Herbert EW Jr, Thompson MJ. Sterols of organs involved in brood food production and of royal jelly in honey bees. Insect Biochem 1986;16:479-82.
21. Lercker G, Capella P, Conte LS, Ruini F, Giordani G. Components of royal jelly II. The lipid fraction, hydrocarbons and sterols. J Apicult Res 1982;21:178-84.
22. Blum MS, Novk AF, Taber S. 10-Hydroxy-delta 2-decenoic acid, an antibiotic found in royal jelly. Science 1959;130:452-3.
23. Townsend GF, Morgan JF, Hazlett B. Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukaemia and ascetic tumours. Nature 1959;183:1270-1.
24. Okuda H, Kameda K, Morimoto C, Matsuura Y, Chikaki M, Jiang M. Studies on insulin-like substances and inhibitory substances toward angiotensin-converting enzyme in royal jelly. Honeybee Sci 1998;19:9-14 (in Japanese).
25. Koya-Miyata S, Okamoto I, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Biosci Biotechnol Biochem 2004;68:767-73.
26. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
27. Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, Araki Y, et al. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem 2006;70:2508-14.
28. Hidaka S, Okamoto Y, Uchiyama S, Nakatsuma A, Hashimoto K, Ohnishi ST, et al. Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Complement Alternat Med 2006;3:339-48.
29. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-70.
30. Vallette G, Christeff N, Bogard C, Benassayag C, Nunez E. Dynamic pattern of estradiol binding to uterine receptors of the rat. Inhibition and stimulation by unsaturated fatty acids. J Biol Chem 1988;263:3639-45.
31. Borras M, Leclercq G. Modulatory effect of nonesterified fatty acids on structure and binding characteristics of estrogen receptor from MCF-7 human breast cancer cells. J Recept Res 1992;12:463-84.
32. Liu J, Burdette JE, Sun Y, Deng S, Schlecht SM, Zheng W, et al. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004;11:18-23.
33. Burns CP, Luttenegger DG, Dudley DT, Buettner GR, Spector AA. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells. Cancer Res 1979;39:1726-32.